The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
COMy Virtual 2020 | Myeloma: BiTEs & CARs
Shaji Kumar, MD, Mayo Clinic, Rochester, MN, provides a rundown of the immunotherapies currently available for the treatment of multiple myeloma, the limitations and where research is likely to take the field. Specifically discussed is CAR T-cell therapy and bispecific T-cell engagers (BiTEs) such as AMG 420. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
